Skip to article
Astra

Infectious Diseases

Toxic Shock Syndrome

Toxic shock syndrome is a rapidly progressive toxin-mediated shock syndrome from Staphylococcus aureus or group A Streptococcus. Treat suspected disease before surveillance criteria are complete: resuscitate, obtain cultures, remove or debride the source, and provide pathogen-directed antitoxin therapy.

Clinical question: How should clinicians recognize and immediately manage suspected staphylococcal or streptococcal toxic shock syndrome?

Recognition

Recognize TSS before surveillance criteria are complete

TSS is a clinical emergency, not a diagnosis to defer pending desquamation or microbiologic confirmation.

TSS results from toxin-producing Staphylococcus aureus or Streptococcus pyogenes. Superantigen activity causes broad T-cell activation and cytokine release, producing capillary leak, hypotension, and multiorgan dysfunction. CDCSuperantigens and Streptococcal Toxic Shock Syndrome - Volume 9, Number 10—October 2003 - Emerging Infectious Diseases journal - CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf STSS is defined by GAS infection with abrupt shock and organ failure; hypotension generally develops within 24 to 48 hours after initial symptoms. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC

A diffuse rash is helpful but not required for early action. In a pediatric series, 48% of STSS cases lacked rash; delayed use of clindamycin and IVIG was associated with longer hospitalization among children without rash. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC TSS may arise from a small or occult focus, and blood cultures can be negative in staphylococcal disease. ScienceDirectLesson of the month 2: Toxic shock syndrome

STSS should be especially considered with severe focal pain out of proportion to examination, recent surgery or skin disruption, varicella-associated skin lesions, diabetes, alcohol use disorder, or age 65 years or older. NSAID exposure may increase risk, although evidence is limited. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC

High-yield distinctions between streptococcal and staphylococcal toxic shock syndromes. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
FeatureSTSSStaphylococcal TSS
Usual microbiologyGroup A Streptococcus infection with hypotension, multiorgan involvement, and isolation of GAS required for the CSTE case definition. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCToxin-producing Staphylococcus aureus; often associated with localized mucosal, wound, or skin infection. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Clinical source patternOften invasive deep-tissue or bloodstream disease; necrotizing fasciitis or myositis may be present. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock SyndromeMay arise from menstrual or nonmenstrual localized sources, including wounds, burns, retained foreign material, or packing. ScienceDirectLesson of the month 2: Toxic shock syndromePubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
RashMay be absent; do not use its absence to lower urgency. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCDiffuse erythroderma and later desquamation are characteristic but may not be present initially. PubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
PrognosisCDC states mortality can exceed 30% despite aggressive treatment. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCMortality varies by syndrome and setting; prompt recognition, source control, and supportive care remain essential. ScienceDirectLesson of the month 2: Toxic shock syndromePubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf

Diagnosis

Order cultures and organ-injury testing while resuscitation proceeds

The diagnostic task is to establish a toxin-mediated syndrome, identify the organism and source, and exclude competing causes of shock.

There is no single diagnostic test for TSS. Obtain blood cultures and cultures from any suspected source before antimicrobials when this does not delay treatment. Evaluate organ involvement with CBC and platelets, comprehensive metabolic panel, creatine kinase, coagulation studies, urinalysis, and assessment for pulmonary involvement. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf

For STSS surveillance classification, the CSTE case definition requires hypotension, multiorgan involvement, and GAS isolation; isolation from a sterile site supports a confirmed case. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC These criteria optimize specificity and should not be treated as bedside prerequisites for empiric therapy. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC

Early imaging should be directed by the suspected source and must not postpone exploration when necrotizing soft-tissue infection is plausible. In STSS, severe pain can precede prominent local findings, and bullae or violaceous progression should prompt emergent surgical exploration. CDCStreptococcal Toxic-Shock Syndrome

Bedside actions linked to diagnostic findings in suspected TSS. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock SyndromeCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
FindingInterpretationImmediate action
Hypotension with suspected GAS infection and at least two organ-system abnormalitiesMeets the clinical severity framework for STSS; sterile-site GAS establishes confirmed surveillance classification. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock SyndromeTreat as STSS: resuscitate, start penicillin plus clindamycin when GAS is established or strongly suspected, and seek source control. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC
Severe focal pain, rapidly progressive edema/erythema, vesicles, bullae, or violaceous skinSuggests deep soft-tissue infection or necrotizing fasciitis; examination may initially underestimate disease extent. CDCStreptococcal Toxic-Shock SyndromeObtain immediate surgical consultation and explore/debride as indicated; do not await late skin findings. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock Syndrome
Diffuse pulmonary infiltrates, pyuria, or coagulation abnormalitiesMay occur in TSS even when not uniformly represented in case definitions. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCDocument organ involvement, intensify monitoring and organ support, and continue source-directed evaluation. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
No rash or negative blood culturesDoes not exclude TSS, particularly early disease or staphylococcal TSS from a localized source. ScienceDirectLesson of the month 2: Toxic shock syndromeCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCContinue syndrome-based treatment and aggressively search for a source. ScienceDirectLesson of the month 2: Toxic shock syndromePubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf

Management

Resuscitate, control the source, and start antitoxin-active therapy

Early ICU-level care is appropriate when shock or evolving organ failure is present.

Hospitalize patients with suspected STSS. Begin standard shock management with intravenous fluid resuscitation and organ support; add vasopressors when hypotension persists despite fluids. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf Serially reassess hemodynamics, urine output, respiratory failure, renal function, hepatic injury, coagulation abnormalities, and evolving skin or soft-tissue findings. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf

Source control is time-critical. Remove tampons, packing, or other retained foreign material; drain abscesses; and obtain urgent surgical assessment for suspected deep infection. CDC specifically notes that surgical debridement may be necessary in STSS. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC

For confirmed or strongly suspected STSS, CDC identifies penicillin plus clindamycin as first-line antibiotics. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC Clindamycin is used in combination, not alone, because it suppresses toxin production but is bacteriostatic. PubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf The supplied sources do not provide a U.S. dosing regimen for penicillin or clindamycin; use current institutional severe invasive GAS pathways and adjust to kidney function, allergy history, and microbiology results.

Immediate management priorities for suspected TSS. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
PriorityActionPractical endpoint
ShockInitiate intravenous fluid resuscitation and treat shock/organ failure in hospital; use vasopressors for fluid-refractory shock. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI BookshelfStabilizing perfusion and ongoing reassessment for multiorgan failure. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
MicrobiologyDraw blood cultures and culture the suspected source when feasible without delaying treatment. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI BookshelfIdentify GAS, S. aureus, and susceptibility profile; narrow therapy when appropriate. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
AntimicrobialsUse broad empiric coverage when pathogen is unknown; use penicillin plus clindamycin for STSS. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI BookshelfEarly pathogen-directed therapy plus toxin-suppression strategy for GAS. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Source controlRemove foreign material; drain abscesses; urgently debride deep or necrotizing infection. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI BookshelfNo retained nidus or devitalized infected tissue. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock Syndrome
Adjunctive therapyConsider IVIG early in severely ill STSS, recognizing uncertain efficacy. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCAdjunct only; never replaces core resuscitative and source-control measures. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC

Role of intravenous immunoglobulin

CDC states that IVIG can be considered early for severely ill patients with STSS, but efficacy has not been proven. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC A pediatric review found variable outcomes with IVIG and no significant difference in measured outcomes among treatment groups in its retrospective cohort. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC Use should therefore be individualized, generally as an adjunct in severe or refractory toxin-mediated illness after immediate resuscitation, antimicrobials, and source-control planning are underway. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC

Monitoring

Anticipate rapid deterioration and high morbidity

Deterioration can occur within hours, particularly in STSS with deep-tissue infection.

STSS can progress from influenza-like symptoms to hypotension within 24 to 48 hours. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC Organ failure may involve renal, hepatic, respiratory, hematologic, and soft-tissue systems; complications include need for debridement or amputation. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCAbout Streptococcal Toxic Shock Syndrome | Group A Strep | CDC

CDC reports that STSS mortality can exceed 30% despite aggressive treatment and is higher with advancing age. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDC In historical clinical descriptions, deep soft-tissue infection commonly required debridement, fasciotomy, or amputation. CDCStreptococcal Toxic-Shock Syndrome

Monitor serial hemodynamics, vasopressor requirement, urine output and creatinine, platelets and coagulation studies, hepatic tests, oxygenation, CK when myositis is suspected, and repeated examination of the implicated soft-tissue compartment. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock SyndromePubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf

Monitoring domains in severe TSS. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock SyndromePubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
DomainWhat to followConcerning trajectory
PerfusionBlood pressure, vasopressor requirement, mental status, urine output, renal function. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI BookshelfPersistent or worsening shock, oliguria, or progressive kidney injury. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
RespiratoryOxygenation and pulmonary status. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCNew or worsening pulmonary infiltrates or respiratory failure. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC
Hematologic/hepaticPlatelets, coagulation studies, bilirubin, aminotransferases. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI BookshelfProgressive thrombocytopenia, coagulopathy, or hepatic dysfunction. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf
Soft tissuePain, swelling, erythema, bullae, compartment findings, CK when clinically indicated. CDCStreptococcal Toxic-Shock SyndromePubMedToxic Shock Syndrome - StatPearls - NCBI BookshelfRapid local progression or evidence of necrosis requiring operative source control. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock Syndrome

Common questions

Can toxic shock syndrome be diagnosed without rash?

Yes. Rash may be absent early and was absent in 48% of pediatric STSS cases in one series. Absence of rash must not delay resuscitation, cultures, source evaluation, antitoxin-active therapy, or surgical consultation when the clinical syndrome suggests TSS. CDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC

What is the first-line antibiotic regimen for streptococcal toxic shock syndrome?

CDC identifies penicillin plus clindamycin as first-line therapy for STSS. Use clindamycin in combination rather than alone, and pair antibiotics with immediate resuscitation and source control. The supplied sources do not provide dosing; follow current institutional severe invasive GAS protocols. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCPubMedToxic Shock Syndrome - StatPearls - NCBI Bookshelf

When should surgery be involved?

Immediately when deep soft-tissue infection is possible, especially with severe disproportionate pain, rapidly progressive swelling or erythema, vesicles, bullae, violaceous change, or refractory shock. Debridement may be necessary for STSS and should not await definitive imaging or late cutaneous findings. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCStreptococcal Toxic-Shock Syndrome

Should IVIG be routinely given for STSS?

No. CDC permits consideration of IVIG early in severely ill STSS, but states that efficacy has not been proven. It should be individualized as adjunctive therapy after core resuscitation, antimicrobial therapy, and source-control planning are underway. CDCClinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCCDCManifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDC

References

  1. highlights of prescribing informationdailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  2. Colchicine Tablets USP, 0.6 mg These highlights do not include all the information needed to use colchicine safely and effectively. See full prescribing information for COLCHICINE TABLETS. COLCHICINE tablets, USP for oral use Initial U.S. Approval: 1961dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  3. These highlights do not include all the information needed to use colchicine safely and effectively. See full prescribing information for Colchicine Tablets, USP. Colchicine Tablets, USP, for oral use Initial U.S. Approval: 1961dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  4. These highlights do not include all the information needed to use ZOSYN safely and effectively. See full prescribing information for ZOSYN. ZOSYN® (piperacillin and tazobactam) injection, for intravenous use Initial U.S. Approval: 1993dailymed.nlm.nih.gov · dailymed.nlm.nih.gov
  5. Toxic Shock Syndrome Surveillance in the United States ...www.acpjournals.org · www.acpjournals.org
  6. Volume 11 Issue Supplement_1 | Clinical Infectious Diseasesacademic.oup.com · academic.oup.com
  7. Epidemiology of Toxic Shock Syndrome in the United Statesacademic.oup.com · academic.oup.com
  8. Tri-State Toxic-Shock Syndrome Study. II. Clinical and ...academic.oup.com · academic.oup.com
  9. Recurrent Nonmenstrual Toxic Shock Syndromeacademic.oup.com · academic.oup.com
  10. Toxic Shock Syndrome Toxin 1 - an overviewwww.sciencedirect.com · www.sciencedirect.com
  11. Lesson of the month 2: Toxic shock syndromewww.sciencedirect.com · www.sciencedirect.com
  12. Prognostic factors in patients hospitalised with group A ...www.sciencedirect.com · www.sciencedirect.com
  13. Toxic Shock Syndrome - an overviewwww.sciencedirect.com · www.sciencedirect.com
  14. Group A Streptococcal Pharyngitiswww.idsociety.org · www.idsociety.org
  15. Early and Definitive Diagnosis of Toxic Shock Syndrome by Detection of Marked Expansion of T-Cell-Receptor Vβ2-Positive T Cells - Volume 9, Number 3—March 2003 - Emerging Infectious Diseases journal - CDCwwwnc.cdc.gov · wwwnc.cdc.gov
  16. Clinical Guidance for Streptococcal Toxic Shock Syndrome | Group A Strep | CDCwww.cdc.gov · www.cdc.gov
  17. Streptococcal Toxic-Shock Syndromewwwnc.cdc.gov · wwwnc.cdc.gov
  18. Manifestations of Toxic Shock Syndrome in Children, Columbus, Ohio, USA, 2010–2017 - Volume 26, Number 6—June 2020 - Emerging Infectious Diseases journal - CDCwwwnc.cdc.gov · wwwnc.cdc.gov
  19. Superantigens and Streptococcal Toxic Shock Syndrome - Volume 9, Number 10—October 2003 - Emerging Infectious Diseases journal - CDCwwwnc.cdc.gov · wwwnc.cdc.gov
  20. About Streptococcal Toxic Shock Syndrome | Group A Strep | CDCwww.cdc.gov · www.cdc.gov
  21. Toxic Shock Syndrome in Patients Younger than 21 Years ...stacks.cdc.gov · stacks.cdc.gov
  22. Staphylococcal Toxic Shock Syndrome 2000–2006stacks.cdc.gov · stacks.cdc.gov
  23. The Management of Staphylococcal Toxic Shock Syndrome. A Case Report - PMCpmc.ncbi.nlm.nih.gov · pmc.ncbi.nlm.nih.gov
  24. Toxic Shock Syndrome - StatPearls - NCBI Bookshelfwww.ncbi.nlm.nih.gov · www.ncbi.nlm.nih.gov